Arbutus Biopharma (ABUS) Non Operating Investment Income (2018)

Arbutus Biopharma has reported Non Operating Investment Income for 1 years, with the latest figure at $24.9 million in Q2 2018.

• Quarterly Non Operating Investment Income changed N/A year-over-year to $24.9 million in Q2 2018, while the trailing twelve-month figure through Jun 2019 was $24.9 million (changed 0.0% YoY) and the FY2018 annual result came in at $24.9 million, changed N/A from the prior year.
• Non Operating Investment Income steadied at $24.9 million in Q2 2018 per ABUS's latest filing.
• Over five years, Non Operating Investment Income peaked at $24.9 million in Q2 2018 and troughed at $24.9 million in Q2 2018.